Moreno C, Byrd JC, Hillmen P, et al. Ibrutinib in previously treated chronic lymphocytic leukemia updated efficacy and safety of the RESONATE study with up to four years of follow-up. EHA 2017, abstract S769.
Voorlopige resultaten CAR NK-celtherapie bij NHL en CLL
feb 2020 | Leukemie, Lymfoom